Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 6/20 | 0.47 |
| ▸ | CA2 | P00918 | 6/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.47 |
| ▸ | CA9 | Q16790 | 5/20 | 0.45 |
| ▸ | MAPT | P10636 | 5/20 | 0.40 |
| ▸ | NPC1 | O15118 | 3/20 | 0.40 |
| ▸ | RAB9A | P51151 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 3/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.38 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19393344 | 0.81 | CA12 (0.71) | CA12CA2KDM4ECA9MAPT | |
| SCHEMBL16660367 | 0.81 | MAPT (0.53) | CA12CA2KDM4ECA9MAPT | |
| SCHEMBL346793 | 0.80 | CA12 (0.60) | CA12CA2KDM4ECA9MAPT | |
| SCHEMBL16660366 | 0.80 | CA12 (0.68) | CA12CA2KDM4ECA9MAPT | |
| SCHEMBL16221721 | 0.77 | CA12 (0.78) | CA12CA2KDM4ECA9MAPT | |
| SCHEMBL29610101 | 0.77 | CA12 (0.78) | CA12CA2KDM4ECA9MAPT | |
| SCHEMBL5350861 | 0.77 | CA12 (0.78) | CA12CA2KDM4ECA9MAPT | |
| SCHEMBL19209979 | 0.77 | CA12 (0.78) | CA12CA2KDM4ECA9MAPT | |
| SCHEMBL12996009 | 0.77 | CA12 (0.78) | CA12CA2KDM4ECA9MAPT | |
| SCHEMBL16247111 | 0.76 | CA12 (0.70) | CA12CA2KDM4ECA9MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150110715-A1 | Double-Labeled Probe for Molecular Imaging and Use Thereof | RUPRECHT-KARLS-UNIVERSITAT HEIDELBERG (DE) | 2015-04-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150110715-A1 | Double-Labeled Probe for Molecular Imaging and Use Thereof | CD47, ANXA5, CD44 | CA12 44/4885CA2 73/4885KDM4E 2876/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.